Genmab A (GMAB) Inventory (2023 - 2025)

Genmab A's Inventory history spans 3 years, with the latest figure at $18.0 million for Q4 2025.

  • For Q4 2025, Inventory rose 100.0% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $18.0 million, up 100.0%, while the annual FY2025 figure was $18.0 million, 100.0% up from the prior year.
  • Inventory reached $18.0 million in Q4 2025 per GMAB's latest filing, up from $9.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $18.0 million in Q4 2025 to a low of $8.0 million in Q4 2023.
  • Average Inventory over 3 years is $11.7 million, with a median of $9.0 million recorded in 2024.
  • Peak YoY movement for Inventory: rose 12.5% in 2024, then soared 100.0% in 2025.
  • A 3-year view of Inventory shows it stood at $8.0 million in 2023, then grew by 12.5% to $9.0 million in 2024, then skyrocketed by 100.0% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Inventory are $18.0 million (Q4 2025), $9.0 million (Q4 2024), and $8.0 million (Q4 2023).